|
Synonyms: GSK3882347
Compound class:
Synthetic organic
Comment: Luxafimloc (also known as GSK3882347) is an orally bioavailable, mannose-containing small molecule with promising anti-virulence activity against uropathogenic Gram-negative bacteria. The chemical structure is claimed in GSK patent WO2020012336A1 [1] and was presented during the ACS Fall 2026 meeting's First Time Disclosures session [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 14162 | luxafimloc |
Synonyms ![]() |
| GSK3882347 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
GSK3882347 |
| Other databases | |
| CAS Registry No. | 2408524-70-7 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL6102250 |
| GtoPdb PubChem SID | 530846940 |
| PubChem CID | 146296584 |
| Search Google for chemical match using the InChIKey | MDGCFZRSOKMPFJ-QONVVCGCSA-N |
| Search Google for chemicals with the same backbone | MDGCFZRSOKMPFJ |
| Search PubMed clinical trials | luxafimloc |
| Search PubMed titles | luxafimloc |
| Search PubMed titles/abstracts | luxafimloc |
| UniChem Compound Search for chemical match using the InChIKey | MDGCFZRSOKMPFJ-QONVVCGCSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | MDGCFZRSOKMPFJ-QONVVCGCSA-N |